Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Geriatrics Reports
Published in: Current Geriatrics Reports 3/2013

01-09-2013 | Infectious Diseases in the Elderly (SF Bradley, Section Editor)

The Epidemiology and Clinical Impact of Surgical Site Infections in the Older Adult

Authors: Natasha Bagdasarian, Kenneth E. Schmader, Keith S. Kaye

Published in: Current Geriatrics Reports | Issue 3/2013

Login to get access

Abstract

Surgical site infections (SSI) are the second most frequent healthcare-associated infection (HAI), accounting for approximately 20 % of all HAIs in the United States, and an important cause of morbidity and mortality in older adults. With the aging of the population and the expected increase in surgical procedures in the elderly, strategies for prevention and treatment of SSI, will assume increased importance. In this review we describe risk factors for and outcomes associated with SSI, and recommend treatment and prevention strategies for SSI in older adults.
Literature
1.
Popovic JR, Kozak LJ. National hospital discharge survey: annual summary, 1998. Vital Health Stat. 2000;13(148):1–194.
2.
Cram P, Lu X, Kates SL, et al. Total knee arthroplasty volume, utilization, and outcomes among Medicare beneficiaries, 1991–2010. JAMA. 2012;308(12):1227–36.PubMedCrossRef
3.
Deyo RA, Mirza SK, Martin BI, et al. Trends, major medical complications, and charges associated with surgery for lumbar spinal stenosis in older adults. JAMA. 2010;303(13):1259–65.PubMedCrossRef
4.
Anderson GF, Hussey PS. Population aging: a comparison among industrialized countries. Health Aff (Millwood). 2000;19(3):191–203.CrossRef
5.
Trends in aging—United States and worldwide. MMWR Morb Mortal Wkly Rep. 2003 Feb 14;52(6):101–4, 6.
6.
Agarwal S, Busse PJ. Innate and adaptive immunosenescence. Ann Allergy Asthma Immunol. 2010;104(3):183–90. quiz 90–2, 210.PubMedCrossRef
7.
Mu Y, Edwards JR, Horan TC, et al. Improving risk-adjusted measures of surgical site infection for the national healthcare safety network. Infect Control Hosp Epidemiol. 2011;32(10):970–86.PubMedCrossRef
8.
Klevens RM, Edwards JR, Richards Jr CL, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122(2):160–6.PubMed
9.
• Calderwood MS, Kleinman K, Bratzler DW, et al. Use of Medicare claims to identify US hospitals with a high rate of surgical site infection after hip arthroplasty. Infect Control Hosp Epidemiol. 2013;34(1):31–9. Retrospective cohort study in which Medicare claims were successfully used to identify US hospitals with high rates of surgical site infection (SSI) after hip arthroplasty.PubMedCrossRef
10.
Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999;20(4):250–78. quiz 79–80.PubMedCrossRef
11.
Daneman N, Lu H, Redelmeier DA. Discharge after discharge: predicting surgical site infections after patients leave hospital. J Hosp Infect. 2010;75(3):188–94.PubMedCrossRef
12.
13.
Haley VB, Van Antwerpen C, Tserenpuntsag B, et al. Use of administrative data in efficient auditing of hospital-acquired surgical site infections, New York State 2009–2010. Infect Control Hosp Epidemiol. 2012;33(6):565–71.PubMedCrossRef
14.
Perencevich EN, Sands KE, Cosgrove SE, et al. Health and economic impact of surgical site infections diagnosed after hospital discharge. Emerg Infect Dis. 2003;9(2):196–203.PubMedCrossRef
15.
Tanner J, Padley W, Kiernan M, et al. A benchmark too far: findings from a national survey of surgical site infection surveillance. J Hosp Infect. 2013;83(2):87–91.PubMedCrossRef
16.
Lepelletier D, Ravaud P, Baron G, et al. Agreement among health care professionals in diagnosing case Vignette-based surgical site infections. PLoS One. 2012;7(4):e35131.PubMedCrossRef
17.
Anderson DJ, Kaye KS, Classen D, et al. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29 Suppl 1:S51–61.PubMedCrossRef
18.
19.
20.
Talbot TR, Schaffner W. Relationship between age and the risk of surgical site infection: a contemporary reexamination of a classic risk factor. J Infect Dis. 2005;191(7):1032–5.PubMedCrossRef
21.
Richards JE, Kauffmann RM, Zuckerman SL, et al. Relationship of hyperglycemia and surgical-site infection in orthopaedic surgery. J Bone Joint Surg Am. 2012;94(13):1181–6.PubMedCrossRef
22.
• Namba RS, Inacio MC, Paxton EW. Risk factors associated with surgical site infection in 30,491 primary total hip replacements. J Bone Joint Surg Br. 2012;94(10):1330–8. A retrospective review of a cohort of primary total hip replacement (THR) performed between 2001 and 2009, to identify patient and surgical factors associated with deep surgical site infection (SSI) following THR.PubMed
23.
de Boer AS, Mintjes-de Groot AJ, Severijnen AJ, et al. Risk assessment for surgical-site infections in orthopedic patients. Infect Control Hosp Epidemiol. 1999;20(6):402–7.PubMedCrossRef
24.
Scott JD, Forrest A, Feuerstein S, et al. Factors associated with postoperative infection. Infect Control Hosp Epidemiol. 2001;22(6):347–51.PubMedCrossRef
25.
Kaye KS, Schmit K, Pieper C, et al. The effect of increasing age on the risk of surgical site infection. J Infect Dis. 2005;191(7):1056–62.PubMedCrossRef
26.
Malone DL, Genuit T, Tracy JK, et al. Surgical site infections: reanalysis of risk factors. J Surg Res. 2002;103(1):89–95.PubMedCrossRef
27.
Kaye KS, Sloane R, Sexton DJ, et al. Risk factors for surgical site infections in older people. J Am Geriatr Soc. 2006;54(3):391–6.PubMedCrossRef
28.
Lee J, Singletary R, Schmader K, et al. Surgical site infection in the elderly following orthopaedic surgery. Risk factors and outcomes. J Bone Joint Surg Am. 2006;88(8):1705–12.PubMedCrossRef
29.
Kaye KS, Schmader KE, Sawyer R. Surgical site infection in the elderly population. Clin Infect Dis. 2004;39(12):1835–41.PubMedCrossRef
30.
Bratzler DW, Hunt DR. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis. 2006;43(3):322–30.PubMedCrossRef
31.
• Chen TY, Anderson DJ, Chopra T, et al. Poor functional status is an independent predictor of surgical site infections due to methicillin-resistant Staphylococcus aureus in older adults. J Am Geriatr Soc. 2010;58(3):527–32. Risk factors for MRSA SSI were identified by comparing cases with uninfected surgical patients and patients with SSI due to MSSA.PubMedCrossRef
32.
Anderson DJ, Arduino JM, Reed SD, et al. Variation in the type and frequency of postoperative invasive Staphylococcus aureus infections according to type of surgical procedure. Infect Control Hosp Epidemiol. 2010;31(7):701–9.PubMedCrossRef
33.
Anderson DJ, Kaye KS, Chen LF, et al. Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: a multi-center matched outcomes study. PLoS One. 2009;4(12):e8305.PubMedCrossRef
34.
Ming DY, Chen LF, Miller BA, et al. The impact of depth of infection and postdischarge surveillance on rate of surgical-site infections in a network of community hospitals. Infect Control Hosp Epidemiol. 2012;33(3):276–82.PubMedCrossRef
35.
May AK. Skin and soft tissue infections: the new surgical infection society guidelines. Surg Infect (Larchmt). 2011;12(3):179–84.PubMedCrossRef
36.
Osmon DR, Berbari EF, Berendt AR, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the infectious diseases society of america. Clin Infect Dis. 2013;56(1):e1–e25.PubMedCrossRef
37.
White PF, White LM, Monk T, et al. Perioperative care for the older outpatient undergoing ambulatory surgery. Anesth Analg. 2012;114(6):1190–215.PubMedCrossRef
38.
Pritchard L, Baker C, Leggett J, et al. Increasing vancomycin serum trough concentrations and incidence of nephrotoxicity. Am J Med. 2010;123(12):1143–9.PubMedCrossRef
39.
Finlayson E, Maselli J, Steinman MA, et al. Inappropriate medication use in older adults undergoing surgery: a national study. J Am Geriatr Soc. 2011;59(11):2139–44.PubMedCrossRef
40.
Kirkland KB, Briggs JP, Trivette SL, et al. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol. 1999;20(11):725–30.PubMedCrossRef
41.
Cruse PJ, Foord R. The epidemiology of wound infection. A 10-year prospective study of 62,939 wounds. Surg Clin North Am. 1980;60(1):27–40.PubMed
42.
43.
•• Kaye KS, Anderson DJ, Sloane R, et al. The effect of surgical site infection on older operative patients. J Am Geriatr Soc. 2009;57(1):46–54. Retrospective matched-outcomes study comparing older post-operative patients with deep incisional or organ/space SSI to operative patients without SSI. This study found increased mortality, length of stay and healthcare costs in elderly patients with SSI.PubMedCrossRef
44.
Coello R, Glenister H, Fereres J, et al. The cost of infection in surgical patients: a case-control study. J Hosp Infect. 1993;25(4):239–50.PubMedCrossRef
45.
Hollenbeak CS, Murphy DM, Koenig S, et al. The clinical and economic impact of deep chest surgical site infections following coronary artery bypass graft surgery. Chest. 2000;118(2):397–402.PubMedCrossRef
46.
Whitehouse JD, Friedman ND, Kirkland KB, et al. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol. 2002;23(4):183–9.PubMedCrossRef
47.
Skoufalos A, Clarke JL, Napp M, et al. Improving awareness of best practices to reduce surgical site infection: a multistakeholder approach. Am J Med Qual. 2012;27(4):297–304.PubMedCrossRef
48.
McGarry SA, Engemann JJ, Schmader K, et al. Surgical-site infection due to Staphylococcus aureus among elderly patients: mortality, duration of hospitalization, and cost. Infect Control Hosp Epidemiol. 2004;25(6):461–7.PubMedCrossRef
49.
Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt). 2013;14(1):73–156.PubMedCrossRef
50.
Harbarth S, Samore MH, Lichtenberg D, et al. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation. 2000;101(25):2916–21.PubMedCrossRef
51.
Coakley BA, Sussman ES, Wolfson TS, et al. Postoperative antibiotics correlate with worse outcomes after appendectomy for nonperforated appendicitis. J Am Coll Surg. 2011;213(6):778–83.PubMedCrossRef
52.
53.
Nelson RL, Glenny AM, Song F. Antimicrobial prophylaxis for colorectal surgery. Cochrane Database Syst Rev. 2009;1, CD001181.PubMed
54.
Lazar HL, McDonnell M, Chipkin SR, et al. The Society of Thoracic Surgeons practice guideline series: blood glucose management during adult cardiac surgery. Ann Thorac Surg. 2009;87(2):663–9.PubMedCrossRef
55.
Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. Study of Wound Infection and Temperature Group. N Engl J Med. 1996;334(19):1209–15.PubMedCrossRef
56.
Blatteis CM. Age-dependent changes in temperature regulation - a mini review. Gerontology. 2012;58(4):289–95.PubMedCrossRef
57.
van Rijen M, Bonten M, Wenzel R, et al. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev. 2008;4, CD006216.PubMed
58.
Bratzler DW, Dellinger EP, Olsen KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70(3):195–283.PubMedCrossRef
59.
Bode LG, Kluytmans JA, Wertheim HF, et al. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med. 2010;362(1):9–17.PubMedCrossRef
60.
61.
Huttner B, Robicsek AA, Gervaz P, et al. Epidemiology of methicillin-resistant Staphylococcus aureus carriage and MRSA surgical site infections in patients undergoing colorectal surgery: a cohort study in two centers. Surg Infect (Larchmt). 2012;13(6):401–5.PubMedCrossRef
62.
Bull AL, Worth LJ, Richards MJ. Impact of vancomycin surgical antibiotic prophylaxis on the development of methicillin-sensitive staphylococcus aureus surgical site infections: report from Australian Surveillance Data (VICNISS). Ann Surg. 2012;256(6):1089–92.PubMedCrossRef
Metadata
Title
The Epidemiology and Clinical Impact of Surgical Site Infections in the Older Adult
Authors
Natasha Bagdasarian
Kenneth E. Schmader
Keith S. Kaye
Publication date
01-09-2013
Publisher
Springer US
Published in
Current Geriatrics Reports / Issue 3/2013
Electronic ISSN: 2196-7865
DOI
https://doi.org/10.1007/s13670-013-0048-3

Other articles of this Issue 3/2013

Current Geriatrics Reports 3/2013 Go to the issue

Infectious Diseases in the Elderly (SF Bradley, Section Editor)

Impact and Management of MRSA in the Long-Term Care Setting

Neurology of Aging (KS Marder, Section Editor)

Update on Dementia with Lewy Bodies

NEUROLOGY OF AGING (K MARDER, SECTION EDITOR)

Treatment of Alzheimer’s Disease: Current Management and Experimental Therapeutics

Neurology of Aging (KS Marder, Section Editor)

Primary Central Nervous System Tumors in the Aging Population

Infectious Diseases in the Elderly (SF Bradley, Section Editor)

Emergence and Control of Antibiotic-resistant Gram-negative Bacilli in Older Adults

Neurology of Aging (KS Marder, Section Editor)

Vascular Dementia
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits